• Vitiligo: A Step-By-Step Guide To Diagnosis, Treatment And Prophylaxis

    Vitiligo: A Step-By-Step Guide To Diagnosis, Treatment And Prophylaxis

    Publication: November 2017.
    397 pages
    This book is a collection of protocols and tips regarding how to diagnose, treat and follow-up with vitiligo patients. It is an invaluable resource for anyone who studies or treats this disease. Each of ten chapters features the experiences and opinions of vitiligo specialists from across the world – scientists, doctors and academics with vast experience and knowledge, who are all recognized as leaders in their field. This is not a consensus or generalized approach, but rather a practical, step-by-step guide for daily use by a doctor.


    Publication: November 2017.
    232 pages
    This book is best described as a practical guide to vitiligo for patients who have been looking for a better way to manage vitiligo. Yan Valle will cut through all the clutter surrounding vitiligo, debunk some common myths, and reveal what patients really need to know to understand and manage vitiligo with minimal effort. It contains the hidden truth about vitiligo and its connection with other diseases, common household items, daily stress and environmental factors. A thoroughly researched, easy-to-read and jargon-free guide to vitiligo – this is essential reading for vitiligo patients, or anyone interested in the condition.


    Publication: June 2013.
    528 pages
    Vitiligo is still a stigmatizing and enigmatic spectrum of disorders in which too much contradictory data and too many hypotheses are still confusing the scientific community and the patients who are seeking for the cure or at least for a satisfactory treatment.In this e-book the Editors try with the help of the most prestigious experts in the world to answer the available truth on three main questions: Vitiligo, what are you ? How do we treat vitiligo? Quo Vadis, vitiligo?
Using methotrexate in the treatment of advanced vitiligo.Accepted for publication by the Journal of Cosmetic Dermatology.
Exploring the Natural and Treatment History of Vitiligo: Findings From the Global VALIANT Study.Presented at Maui Derm.
Emerging drugs for the treatment of vitiligo.Expert Opinion on Emerging Drugs (IEMD). 2020 Jan.
Therapeutic Options in Vitiligo with Special Emphasis on Immunomodulators: A Comprehensive Update with Review of Literature.Dermatol Ther. 2019 Dec 31:e13215. doi: 10.1111/dth.13215
X Interactive Course “Dermatologia Pediatrica del Mediterraneo”.Dermatol Ther. 2019 Sep 26. doi: 10.1111/dth.13105
How the globe celebrated World Vitiligo Day 2019.Dermatol Ther. 2019 Sep 10:e13085. doi: 10.1111/dth.13085
World Vitiligo Day-A grassroots campaign to improve the quality of life of vitiligo patientsDermatol Ther. 2019 Sep;32(5):e13050. doi: 10.1111/dth.13050. Epub 2019 Aug 22.
The XIX National Congress of the Russian Society of Dermatology and Venereology has been celebrated in Moscow, Russia on June 18‐21, 2019.Dermatol Ther. Epub July 2019 doi: 10.1111/dth.13024
Lotti T, Wollina U, Tchernev G, Valle Y, Lotti J, França K, Satolli F, Rovesti, Tirant M, Lozev I, Pidakev I Gianfaldoni S.An Innovative Therapeutic Protocol for Vitiligo: Experience with the Use of Fraxel Herbium Laser, Topical Latanoprost and Successive Irradiation with UVA - 1 LaserAccess Maced J Med Sci.
Valle Y, Korobko I, França K, Lotti T.Patient-reported outcomes: A 5-year long study reveals previously unreported therapeutic, demographic, socio-economic, and other correlations in vitiligo.
Lotti T, Gianfaldoni S, Valle Y, Rovesti M, Feliciano C, Satolli F.Controversial issues in vitiligo patients: a review of old and recent treatments.
Di Nardo V, Barygina V, França K, Tirant M, Valle Y, Lotti T.Functional nutrition as integrated approach in vitiligo management.
A. Goren, Ž. Bolanča, T. Lotti, M. Šitum."Novel technique for repigmentation of senescence grey hair".Dermatologic Therapy. Volume 30, Issue 2, March/April 2017
Roccia M, França K, Castillo D, Tchernev G, Wollina U, Tirant M, Valle Y, Guarneri C, Fioranelli M, Lotti T.Artificial Hair: By the Dawn to Automatic Biofibre® Hair Implant.Open Access Maced J Med Sci.
Stefan G. Vanderweil, Shinya Amano, Wei-Che Ko, Jillian M. Richmond, Michelle Kelley, Maryanne Makredes Senna, Andrea Pearson, Sandhya Chowdary, Celia Hartigan, Bruce Barton, John E. Harris"A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo".J AM ACAD DERMATOL January 2017
R. Spritz et all“Enhanced genome-wide association studies of autoimmune vitiligo identify 23 novel loci and highlight key pathobiological pathways and causal regulatory variation”.Nature Genetics. October 10, 2016. doi:10.1038/ng.3680
Zhang Y, Cai Y, Shi M, Jiang S, Cui S, Wu Y, et al. (2016)“The Prevalence of Vitiligo: A Meta- Analysis”.PLoS ONE 11(9): e0163806. doi:10.1371/ journal.pone.0163806
A.A. Kassymkhanova, G.K. Askarova, Y.Valle, I.V. Korobko, K.M. Lomonosov, G.B. Nurmagabetova, A.Stanimirovic.“Methods Of Vitiligo Treatment”.ISBN 978-601-80599-3-3. 352 pages. September 2016.
R. Kumar, D. Parsad, S. Rani, S. Bhardwaj, N. SrivastavGlabrous lesional stem cells differentiated into functional melanocytes: new hope for regimentationJEADV, DOI: 10.1111/jdv.13686. March 2016
Harris JECellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligoImmunol Rev. 2016 Jan; 269 (1):11-25
Agarwal P, Rashighi M, Essien KI, Richmond JM, Randall L, Pazoki-Toroudi H, Hunter CA, Harris JESimvastatin prevents and reverses depigmentation in a mouse model of vitiligoJ Invest Dermatol. 2015 Apr;135(4):1080-8.
Li Zhou, Yu-Ling Shi, Kai Li, Iltefat Hamzavi, Tian-Wen Gao, Richard H. Huggins, Henry W. Lim and Qing-Sheng MiIncreased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development. Pigment Cell Melanoma Res2015 May;28(3):324-9. doi: 10.1111/pcmr.12355. Epub 2015 Feb 13. PMID: 25604047
Korobko IV, Lomonosov KMApplication of peptidoglycan with immunomodulating activity in vitiligo therapyRussian Journal of Skin and Venerial Diseases. 2015, 18(4): 44-46.
Tsiskarishvili NV, Katsitadze A, Tsiskarishvili NI, Chitanava LPeculiarities of cytokine status in patients with vitiligo and stress in anamnesisGeorgian Med News. 2014 Oct;(235): 45-8
Mirna Situm, Andrija StanimirovichVITILIGO. Perspektive i smjernice.ISBN 978-953-7959-26-5 HDVD HLZ-a
Sun Y, Wu Y, Xiao B, Li L, Li L, Chen HD, Gao XHTreatment of 308nm Excimer Laser on Vitiligo: a Systemic Review of Randomized Controlled Trials.J Dermatolog Treat. 2014 Nov 27:1-21
Korobko IV, Lomonosov KMVitamin E in vitiligo: towards solving the mystery.Pigmentary Disorders 1:133. doi: 10.4172/jpd.1000133
Xiao BH, Wu Y, Sun Y, Chen HD, Gao XHTreatment of vitiligo with NB-UVB: A systematic reviewJ Dermatolog Treat. 2014 Aug 26:1-7. PMID: 25102894
Korobko IV, Lomonosov KMAcridone acetic acid, sodium salt, as an agent to stop vitiligo progression: a pilot study.Dermatol Ther. 2014 Feb 18. doi: 10.1111/dth.12121. PMID: 24548590
Rashighi M, Agarwal P, Richmond JM, Harris TH, Dresser K, Su MW, Zhou Y, Deng A, Hunter CA, Luster AD, Harris JECXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo.Sci Transl Med. 2014 Feb 12;6(223):223ra23. [PMID: 24523323]
Shi YL, Weiland M, Lim HW, Mi QS, Zhou LSerum miRNA expression profiles change in autoimmune vitiligo in mice.Exp Dermatol. 2014 Feb;23(2):140-2 [PMID: 24401108]
Valle Y.Vitiligo: Challenges and Opportunities for Social Entrepreneurs and Communities.Pigmentary Disorders 2014, 1:5
Valle Y.World Vitiligo Day Campaign. Letter to Editor. Journal Of Pigmentary Disorders.Pigmentary Disorders 2014, 1:1
Shi YL, Li K, Hamzavi I, Lim HW, Zhou L, Mi QS.Elevated circulating soluble interleukin-2 receptor in patients with non-segmental vitiligo in North AmericanJ Dermatol Sci. 2013 Sep; 71(3):212-4
Shi YL, Weiland M, Li J, Hamzavi I, Henderson M, Huggins RH, Mahmoud BH, Agbai O, Mi X, Dong Z, Lim HW, Mi QS, Zhou L.MicroRNA expression profiling identifies potential serum biomarkers for non-segmental vitiligoPigment Cell Melanoma Res. 2013 May; 26(3):418-21
Lomonosov K.M., Simonova N.I., Lomonosov M.K.Comparative analysis of serum autoantibodies in vitiligo patientsRuss J Skin Sex Transm Dis. 2013; (2): 35-39
Valle, Y., Lotti, T. M., Hercogova, J., Schwartz, R. A. and Korobko, I. V.Multidisciplinary approach to R&D in vitiligo, a neglected skin disease(2012) Dermatologic Therapy, 25: S1–S9
Hercogová, J., Schwartz, R. A. and Lotti, T. M.Classification of vitiligo: a challenging endeavor(2012) Dermatologic Therapy, 25: S10–S16
Korobko, I. V.Review of current clinical studies of vitiligo treatments(2012) Dermatologic Therapy, 25: S17–S27
Teovska Mitrevska, N., Eleftheriadou, V. and Guarneri, F.Quality of life in vitiligo patients.(2012) Dermatologic Therapy, 25: S28–S31
Lotti, T. M., Hercogová, J., Schwartz, R. A., Tsampau, D., Korobko, I., Pietrzak, A., Mitrevska, N. T., Valle, Y. and Buggiani, G.Treatments of vitiligo: what's new at the horizon(2012) Dermatologic Therapy, 25: S32–S40
Pietrzak, A., Bartosińska, J., Hercogová, J., Lotti, T. M. and Chodorowska, G.Metabolic syndrome in vitiligo(2012) Dermatologic Therapy, 25: S41–S43
Lee, B. W., Schwartz, R. A., Hercogová, J., Valle, Y. and Lotti, T. M.Vitiligo road map(2012) Dermatologic Therapy, 25: S44–S56
Minashkin MM, Salnikova LE, Lomonosov KM, Korobko IV, Tatarenko AO.Possible contribution of GSTP1 and other xenobiotic metabolizing genes to vitiligo susceptibility
Zhou L., Li K., Shi Y.-L., Hamzavi I., Gao T.-W., Henderson M., Huggins R. H., Agbai O., Mahmoud B., Mi X., Lim H. W., Mi Q.-S.Systemic analyses of immunophenotypes of peripheral T cells in non-segmental vitiligo: implication of defective natural killer T-cellsPigment Cell Melanoma Res. 2012; 25(5): 602-611
Babeshko O.A., Lomonosov K.M., Gilyadova N.I.Role of cytokines in vitiligo pathogenesisRuss J Skin Sex Transm Dis. 2012, (3): 37-41
Lomonosov K.M., Mironov A.Yu., Kuznetsov O.V., Babeshko O.A.Virus participation in vitiligo pathogenesisRuss J Skin Sex Transm Dis. 2012; (1): 40-42
Makhov G.I., Lomonosov K.M.Vitiligo: Current state (by the materials of XXII World Congress of Dermatology)Russ J Skin Sex Transm Dis. 2012; (1): 65
Simonova N.I., Lomonosov K.M., Babeshko O.A.Genetic aspects of vitiligo pathogenesis: a review of literatureRuss J Skin Sex Transm Dis. 2012; (5): 56-59
Valle Y., Couture P., Lotti T., Korobko ICloud Medical Research Management (MRM): a Bio-IT tool for correlative studies in dermatologTreat Strategies (Dermatol). 2011; 1(1): 82-86
Lotti T., Hercogova J., Turini D., Tognetti L., Barygina V., Valle Y. (Eds)Natural Antioxidants in General Medicine and in DermatologyWorld Health Academy Publication House (Zurich, CH), 2011
Lomonosov K.M., Esipov D.S., Babeshko O.A., Tatarenko A.O. OOxidative stress in pathogenesis of vitiligoRuss J Skin Sex Transm Dis. 2011; (1): 68-70
Lomonosov K.M.Vitiligo immunopathogenesis and immunocorrector neovir in vitiligo treatmentRuss J Skin Sex Transm Dis. 2010; (2): 36-39
Lomonosov K.M.Oxidative stress and antioxidant therapy in skin diseasesRuss J Skin Sex Transm Dis. 2009; (2): 27-31

FAQOther Questions

  • Can Ginkgo Biloba help with vitiligo?

    Ginkgo Biloba seems to be a simple, safe, inexpensive and fairly effective therapy for vitiligo. It is mostly effective in halting the progression of the disease. It can also sp...

  • Who is prone to vitiligo?

    Scientists know that some people are genetically predisposed to a specific group of autoimmune diseases – including generalized vitiligo – but do not know who and why.It doesn’t...

  • Vitiligo and hearing loss: any connection?

    In short, NO. Recent research shows no relationship between a degree of skin depigmentation and hearing loss severity in vitiligo patients. The results of this study showed tha...